Morocco vs Portugal: Cause of death, by non-communicable diseases, ages 60+
Morocco
80.6%
in 2021
Portugal
81.1%
in 2021
Morocco rank
44th
Portugal rank
41st
Cause of death, by non-communicable diseases, ages 60+ over time
- Morocco
- Portugal
How they compare
Portugal currently reports 81.1% against 80.6% in Morocco, a difference of 0.5%.
The two have swapped places 1 time across 6 shared years of data; in 2000 it was Morocco ahead.
Morocco ranks 44th and Portugal ranks 41st of 185 countries.
Across the 3 decades both report, Morocco averaged higher in 2 and Portugal in 1.
Head to head by decade
| Decade | Morocco | Portugal | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 92.4% | 90.4% | 2.0% | Morocco |
| 2010s | 93.2% | 88.0% | 5.2% | Morocco |
| 2020s | 81.3% | 81.6% | 0.3% | Portugal |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 60+, Morocco or Portugal?
- Portugal, at 81.1% against 80.6% in Morocco as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 60+ between Morocco and Portugal?
- 0.5%, with Portugal ahead.
- How many years of comparable data are there for Morocco and Portugal?
- 6 years are reported by both, from 2000 to 2021.
- How do Morocco and Portugal rank globally for cause of death, by non-communicable diseases, ages 60+?
- Morocco ranks 44th and Portugal ranks 41st of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 60+ (% of total deaths ages 60+). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths ages 60+ due to non-communicable diseases divided by number of all deaths ages 60+, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.